Maximus, Inc. (NYSE:MMS - Get Free Report) Director Jan Madsen sold 2,439 shares of the business's stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Maximus Price Performance
Shares of NYSE MMS opened at $68.74 on Thursday. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The company's 50-day moving average is $71.48 and its 200 day moving average is $78.89. The stock has a market capitalization of $3.89 billion, a P/E ratio of 14.78 and a beta of 0.71.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, sell-side analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.
Maximus Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.75%. The ex-dividend date was Friday, February 14th. Maximus's dividend payout ratio is currently 25.81%.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on MMS. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research report on Thursday, January 2nd. StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.
Check Out Our Latest Research Report on MMS
Institutional Investors Weigh In On Maximus
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in Maximus by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock worth $488,829,000 after purchasing an additional 205,564 shares during the period. Mackenzie Financial Corp grew its holdings in Maximus by 2.0% in the fourth quarter. Mackenzie Financial Corp now owns 2,782,150 shares of the health services provider's stock worth $207,687,000 after purchasing an additional 55,583 shares during the period. Geode Capital Management LLC grew its holdings in Maximus by 1.4% in the third quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider's stock worth $142,109,000 after purchasing an additional 21,532 shares during the period. Dimensional Fund Advisors LP grew its holdings in Maximus by 14.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock worth $105,001,000 after purchasing an additional 177,075 shares during the period. Finally, Van Berkom & Associates Inc. grew its holdings in Maximus by 8.5% in the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock worth $93,792,000 after purchasing an additional 98,264 shares during the period. Hedge funds and other institutional investors own 97.21% of the company's stock.
Maximus Company Profile
(
Get Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
